Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
- PMID: 28276200
- DOI: 10.1111/1471-0528.14619
Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause
Abstract
Background: Vasomotor symptoms (VMSs) are the hallmarks of menopause, occurring in approximately 75% of postmenopausal women in the UK, and are severe in 25%.
Objectives: To identify which treatments are most clinically effective for the relief of VMSs for women in natural menopause without hysterectomy.
Search strategy: English publications in MEDLINE, Embase, and The Cochrane Library up to 13 January 2015 were searched.
Selection criteria: Randomised controlled trials (RCTs) of treatments for women with a uterus for the outcomes of frequency of VMSs (up to 26 weeks), vaginal bleeding, and discontinuation.
Data collection and analysis: Bayesian network meta-analysis (NMA) using mean ratios (MRs) and odd ratios (ORs).
Main results: Across the three networks, 47 RCTs of 16 treatment classes (n = 8326 women) were included. When compared with placebo, transdermal estradiol and progestogen (O+P) had the highest probability of being the most effective treatment for VMS relief (69.8%; MR 0.23; 95% credible interval, 95% CrI 0.09-0.57), whereas oral O+P was ranked lower than transdermal O+P, although oral and transdermal O+P were no different for this outcome (MR 2.23; 95% CrI 0.7-7.1). Isoflavones and black cohosh were more effective than placebo, although not significantly better than O+P. Not only were selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) found to be ineffective in relieving VMSs, but they also had significantly higher odds of discontinuation than placebo. Limited data were available for bleeding, therefore no conclusions could be made.
Conclusion: For women who have not undergone hysterectomy, transdermal O+P was the most effective treatment for VMS relief.
Tweetable abstract: Which treatment best relieves menopause flushes? Results from the #NICE guideline network meta-analysis.
Keywords: Hormonal treatment; menopause; network meta-analysis; uterus.
© 2017 Royal College of Obstetricians and Gynaecologists.
Comment in
-
A pill or a patch for a hot flush?BJOG. 2017 Sep;124(10):1524. doi: 10.1111/1471-0528.14753. Epub 2017 Jul 5. BJOG. 2017. PMID: 28677300 No abstract available.
-
Review: In menopause (intact uterus), estrogen + progestogen, isoflavones, and black cohosh reduce hot flashes.Ann Intern Med. 2017 Sep 19;167(6):JC26. doi: 10.7326/ACPJC-2017-167-6-026. Ann Intern Med. 2017. PMID: 28975316 No abstract available.
Similar articles
-
Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms.J Manag Care Pharm. 2008 Apr;14(3 Suppl):14-9. doi: 10.18553/jmcp.2008.14.S6-A.14. J Manag Care Pharm. 2008. PMID: 18439062 Free PMC article. Review.
-
Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause.Menopause. 2024 Jan 1;31(1):68-76. doi: 10.1097/GME.0000000000002281. Epub 2023 Nov 27. Menopause. 2024. PMID: 38016166
-
Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.J Okla State Med Assoc. 2017 May;110(5):272-274. J Okla State Med Assoc. 2017. PMID: 28649145 Free PMC article. Review.
-
Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.Menopause. 2008 Jan-Feb;15(1):51-8. Menopause. 2008. PMID: 18257142 Clinical Trial.
-
Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.Climacteric. 2012 Apr;15(2):115-24. doi: 10.3109/13697137.2011.624214. Epub 2011 Dec 8. Climacteric. 2012. PMID: 22148909 Review.
Cited by
-
Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life-Results from the Menopause after Cancer (Mac) Study.Cancers (Basel). 2024 Mar 12;16(6):1127. doi: 10.3390/cancers16061127. Cancers (Basel). 2024. PMID: 38539462 Free PMC article.
-
Scale development and validation of perimenopausal women disability index in the workplace.Environ Health Prev Med. 2024;29:4. doi: 10.1265/ehpm.23-00239. Environ Health Prev Med. 2024. PMID: 38311393 Free PMC article.
-
Frequency of Phytoestrogen Consumption and Symptoms at Midlife among Bangladeshis in Bangladesh and London.Nutrients. 2023 Aug 22;15(17):3676. doi: 10.3390/nu15173676. Nutrients. 2023. PMID: 37686708 Free PMC article.
-
Examining the Health-Related Needs of Females during Menopause: A Systematic Review Study.J Menopausal Med. 2023 Apr;29(1):1-20. doi: 10.6118/jmm.22033. J Menopausal Med. 2023. PMID: 37160298 Free PMC article. Review.
-
Phytoestrogens and Health Effects.Nutrients. 2023 Jan 9;15(2):317. doi: 10.3390/nu15020317. Nutrients. 2023. PMID: 36678189 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical